Zyngenia Inc., of Gaithersburg, Md., named David Parkinson head of its clinical advisory board and interim chief medical officer and added him to its board of directors

and Manuela Maronati vice president, sales and marketing, Europe...Valeant Pharmaceuticals International Inc., of Mississauga, Ontario, appointed Robert A. Ingram chairman of the board of directors and named Philip W. Loberg interim chief financial officer

Galapagos NV, of Mechelen, Belgium, elected Ronald Brus to the board of directors...PharmAthene Inc., of Annapolis, Md., appointed Mitchel Sayare to its board of directors

Algeta ASA, of Oslo, Norway, elected Judith Hemberger and Kapil Dhingra to its board of directors

Renhuang Pharmaceuticals Inc., of Harbin, China, appointed Changxiong Sun and Bingchun Wu to its board of directors as independent directors

Oxigene Inc., of South San Francisco, appointed Tamar Howson and its CEO Peter J. Langecker, to its board of directors

Sequenom Inc., of San Diego, appointed Kenneth Buechler and David Pendarvis to its board of directors

Ocular Therapeutix Inc., of Waltham, Mass., named Daniel Myers and Bernard Haffey to its board...Sigma-Aldrich, of St. Louis, appointed George M. Church a director and named George Miller senior vice president, general counsel and secretary

Micromet Inc., of Bethesda, Md., appointed Jan Fagerberg senior vice president and chief medical officer...MorphoSys AG, of Martinsried, Germany, appointed Lisa Rojkjaer vice president and head of clinical development...and promoted David Dodds to president of Sucampo Pharma Europe Ltd

Quanterix Corp., of Cambridge, Mass., appointed David Okrongly CEO and a member of the company's board of directors

Hawaii Biotech Inc., of Honolulu, appointed Michael Spooner to its board of directors

Shire plc, of Basingstoke, UK, appointed Anne Wilms senior vice president and chief information officer...Spartan Bioscience Inc., of Ottawa, Ontario, promoted Mark D. Kershey to president and named Jay Rau director of business development and Susie Kagel director of U.S

N30 Pharma, of Boulder, Colo., made these appointments to its scientific advisory board: Chairman Joseph Loscalzo, Augustine Choi, Michael Marletta, William Sessa and Joseph Vita...Sigma-Aldrich, of St. Louis, appointed Michael Kanan vice president and corporate controller

Geron Corp., of Menlo Park, Calif., appointed Karin Eastham to its board of directors...promoted Stephen DiPalma to executive vice president of business operations and chief financial officer

Cellumen Inc., of Pittsburgh, named Jack A. Reynolds to its board of directors...Novogen Ltd., of New Canaan, Conn., named William D. Rueckert to its board of directors Oxygen Biotherapeutics Inc., of Costa Mesa, Calif., added J. Melville Engle to its board of directors and named Kirk Harrington as head of its warfighter division...Dafna Cohen and Yaron Diament were appointed external directors

VasoGenix Pharmaceuticals Inc., of Lenexa, Kan., added Richard P. Rainey to its board of directors...WuXi PharmaTech, of Shanghai, China, added Stewart Hen and Ning Zhao to its board...XTL Biopharmaceuticals Ltd., of Valley Cottage, N.Y., appointed David Grossman and Boaz Shweiger to its board

VasoGenix Pharmaceuticals, of Lenexa, Kan., elected Richard P. Rainey to its board of directors

Anecova SA, of Geneva, named Barry W. Wilson, Patrick Aebischer and Jeffrey B. Jump to its board...Facet Biotech Corp., of Redwood City, Calif., named Kurt von Emster to its board of directors...Gene Network Sciences Inc., of Cambridge, Mass., named Michael Gilman, founder and CEO of Stromedix Inc., to its board

BioCeramic Therapeutics Ltd., of London, appointed Stephan Rietiker to its board of directors...Ensysce Biosciences Inc., of Houston, appointed Lynn Kirkpatrick president and CEO